Which of the following is true regarding the action potential of skeletal muscle?
**Core Concept**
The action potential in skeletal muscle is a complex electrical and chemical phenomenon that ultimately leads to muscle contraction. It involves the coordinated action of voltage-gated sodium channels, calcium channels, and the release of neurotransmitters like acetylcholine. This process is crucial for the initiation of muscle contraction.
**Why the Correct Answer is Right**
The action potential in skeletal muscle starts with the depolarization of the muscle cell membrane, primarily due to the influx of sodium ions through voltage-gated sodium channels. This depolarization reaches a threshold, triggering the opening of voltage-gated calcium channels, which allows an influx of calcium ions into the cell. The increased calcium concentration triggers the release of more calcium ions from the sarcoplasmic reticulum, leading to muscle contraction. The action potential is a self-regulating process, with the repolarization phase being driven by the efflux of potassium ions.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not accurately describe the action potential in skeletal muscle. The action potential is not solely dependent on the influx of potassium ions.
**Option B:** This option is incorrect as it does not accurately describe the role of calcium ions in the action potential of skeletal muscle. Calcium ions play a crucial role in the release of calcium ions from the sarcoplasmic reticulum, leading to muscle contraction.
**Option C:** This option is incorrect as it does not accurately describe the process of repolarization in skeletal muscle. Repolarization is primarily driven by the efflux of potassium ions, not the influx of sodium ions.
**Clinical Pearl / High-Yield Fact**
The action potential in skeletal muscle is a complex process that involves the coordinated action of multiple ion channels and neurotransmitters. Understanding this process is crucial for diagnosing and treating muscle disorders, such as myasthenia gravis, where the release of acetylcholine is impaired.
**Correct Answer:** D.